Medications: Antithrombotics Flashcards

1
Q

MOA: interacts with antithrombin III to inactivate factor Xa and inhibits the conversion of prothrombin to thrombin (IIa)
* also IXa, Xla, and Xlla

A

Unfractionated Heparin (UFH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • variable response due to binding plasma proteins
  • relatively short t1/2 at therapeutic doses (about 60 minutes)
  • not absorbed orally- IV medication
  • route of adminsitration- IV or subcutaneous
A

unfractionated heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are some indications for unfractionated heparin?

A
  • treatment of acute venous thromboemoblism (VTE) and pulmonary embolism
  • acute MI and unstable angina
  • VTE prophylaxis
  • disseminated intravascular coagulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does activated partial thromboplastin time (aPTT) used for monitoring unfractionated heparin measure?

A
  • measures activities of thrombin and factor Xa
  • monitor theraputic doses of UFH
  • goal: 1.5- 2.5 times control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what labs are used to monitor unfractionated heparin?

A
  • chromogenic antifactor Xa heparin assay
  • activated clotting time (ACT)- higher doses given to pts undergoing PCI and CABG
  • activated partial thromboplastin (aPTT)
  • CBC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are adverse effects of unfractionated heparin?

A
  • bleeding: increased by higher dose, concomitant adminstration of fibrinolytic agents of GPIIb/IIa inhibitors, recent surgery/ trauma/ invasive procedure, hemostatic defects
  • osteoporosis- more for longstanding use
  • increased LFTs
  • heparin induced thrombocytopenia (HIT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • prothrombotic condition associated with increased thrombin
  • caused by heparin dependent antibodies
  • typically occurs 5-10 days after initiation of heparin
  • consider when: platetes decrease by >50% and or throbotic event occurs in patients treated with heparin
A

Heparin induced thrombocytopenia (HIT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

if you suspect HIT, what laboratory testing should be done?

A
  • Ag assays that detect presence of HIT antibodies
  • functional assays that detect evidence of platelet activation (by HIT Ab) in presensce of heparin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the 4Ts probablitity score for HIT? what do the scores mean?

A
  • Thrombocytopenia
  • timing of platelet count fall
  • thrombosis (or other clinical sequelae)
  • other cause of thrombocytopenia
  • 0-3 points = low probablilty
  • 4-5 points = intermediate probabilty
  • 6-8 points = high probability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

treatment of HIT?

A
  • stop all forms of heparin (including flushes and LMWH)
  • Avoid warfarin until platelets recover
  • treatment options: lepirudin, argatroban, bivalirudin
  • fondaparinux
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do you REVERSE unfractionated heparin?

A
  • stop heparin
  • protamine sulfate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

dosing of protamine sulfate? what should you note?

A
  • if 1mg neutralizes approx. 100 units of heparin
  • if 30 minutes have elapsed can give 1/2 dose
  • if >2 hours have elapsed, can give 1/4 dose
  • maximum of 50mg

note
* monitor aPTT
* adverse effects: hypotension, bradycardia
* avoid in patients with fish allergies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA: similar to UFH, except less activity against IIa relative to Xa

A

Lower molecular weight heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what medications are LMWH?

A

enoxaparin
dalteparin (brand only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are indications of LMWH?

A
  • VTE prevention- post surgery, restricted mobility due to acute illness
  • treatment of acute VTE and PE
  • treatment of unstable angina or non-Q wave MI
  • treatment of STEMI
  • Treatment of VTE in cancer patients long term
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

for prophylactic dosing which antithrombotic is preferred when there is renal impairment? LMWH OR UFH?

A

Unfractionated heparin is preferred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what labs should be monitored when using LMWH?

A
  1. Anti-factor Xa level (routine monitoring not indicated ; montitor obese patients, renal insufficiency, pregnancy measure peak (for enoxaparin- 4hrs after dosing)
  2. platelets
  3. CBC
  4. Renal function
  5. weight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are some adverse effects of LMWH?

A

injection site- pain, brusing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how do you reverse LMWH?

A

no proven method for reversal
protamin partially neutralizes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how do you dose protamine in reversal of LMWH?

A
  • <8 hours: 1mg protamine per 1mg enoxaparin
  • 0.5mg protamine per 1mg enoxaparin should be administerd if bleeding continues
  • smaller doses of protamine can be give if the time since LMWH administration is >8 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MOA: indirect factor Xa inhibitor
renally cleared- dose adjust for renal impairment

A

fodaparinux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are indications of Fondaparinux?

A

VTE prophylaxis

23
Q

Adverse effects of fondaparinux?

A

bleeding
injection site reaction

24
Q

Adverse effects of fondaparinux? What should you monitor?

A
  • bleeding
  • injection site reaction

monitoring:
* CBC, Anti factor Xa, renal function

25
Q

MOA: inhibits Vitamin K epoxide which blocks the synthesis of vitamin K-dependent clotting factors; also inhibits synthesis of protein C and S
* II, VII, IX, X

26
Q

what is the effect of warfarin on an established thrombus?

A

no direct effects on established thrombus
* prevents further extension of clot
* prevents secondary thromboemolic complications
* prevents recurrent thromboembolic event

27
Q

How should use of warfarin be monitored?

A

international normalized ratio (INR)
* hospitalized patients: usually daily
* outpatients: every 2-3 days until stable
* then q1 week, q2 weeks, q4 weeks
* CHEST guidlines for consistently stable INRs

CBC
* at least every 6 months

28
Q

what are some contraindications of warfarin?

A
  • active or recent CNS bleeding
  • hemorrhagic tendendices or blood dyscrasias
  • pregnancy
  • trauma or sever bleeding
  • alcoholism
  • significant hx of falls or fall risk
  • recent/anticipated neurosurgical, cerebrospinal or eye surgery
29
Q

which medications when used with warfarin increase the risk of bleeding?

A
  • antiplatelets
  • NSAIDs
30
Q

what are adverse effects of warfarin?

A

Bleeding
* less sever: bruising, epistaxis, gum bleeding
* more severe: GI bleeding, ICH

Other
* skin necrosis
* purple toes syndrome
* teratogenicity

31
Q

what labs should be done before starting warfarin?

A
  • INR
  • CBC with plateltes
  • LFTs
  • pregnancy test
32
Q

What are some reasons for subtheapeutic INR?

A
  • nonadherence
  • large amounts of vitamin K
  • wrong strength
  • ran out of medication
  • drug/diet interaction
  • follow up too soon to see effect
33
Q

reasons for a supratherapeutic INR?

A
  • nonadherence
  • lower amounts of vitamin K than normal
  • wrong strength
  • excessive alcohol intake
  • drug/diet interaction
  • poor nutritional intake
  • acute illness
34
Q

how should you treat subtherapeutic INR?

A

increase weekly dose
consider boost (one-time extra dose)

35
Q

how should you treat supratherapeutic INRs?

A

decrease weekly dose
consider one time dose omission

36
Q

How can Warfarin be reversed?

A
  • stopping warfarin (about 4-5 days for INR to return to baseline)

vitamin K
* oral - may take up to 24 hours to see full effects
* IV: given in hospital; IV route preferred over SQ

Fresh frozen plasma (FFP)
factor VII
Prothrombin complex concentrates

37
Q

treatment for patients with an INR above therapeutic range but <4.5 with no evidence of bleeding?

A

lower or omit dose
* monitor more frequently and resume lower dose
* only if minimally elevated, no dose reduction needed

38
Q

treatment for patient with INR >4.5 but <10.0 with no evidence of bleeding

A

Omit 1-2 doses, monitor more frequently and resume appropriate adjusted dose when INR therapeutic

Routine use of VITAMIN K not recommended

39
Q

treatment for INR > 10 no evidence of bleeding

A

hold warfarin therapy and give vitamin K (2.5-5mg)
resume at appropriate adjusted dose when INR is therapeutic

40
Q

treatment for serious bleeding at any INR elevation?

A

hold warfarin and give vitamin K (5-10mg) by slow IV infusion supplemented with PCC, FFP, or rVIIa

41
Q

what medications are direct oral anticoagulants?

A

dabigatran
rivaroxaban
apixaban
edoxaban

42
Q

What are reversal agents of direct oral anticoagulants?

A

Idaracizumab
adexanet alfa

43
Q

MOA: Humanized monoclonal Ab fragment that binds to diabigatran with an affinity; binds specifically to free and thrombin bound dabigatran

When do you see reversal?

A

Idarucizumab
* 4 hours

44
Q

MOA: recombinant modified human factor Xa protein

Black box warning: thromboembolic risks, ischemic risks, cardiac arrest and suddent deaths

A

andexanet alfa

45
Q

which medications does andexanet alfa reverse?

A

rivaroxaban
apixaban
edoxaban

46
Q

what are benefits of DOACs?

A

fast onset/offset
fixed dosing
limited monitoring
more equal effectiveness
less major bleeding

47
Q

which DOAC is a direct thrombin inhibitor?

A

dabigatran

48
Q

which DOAC is a factor Xa inhibitor?

A

rivaroxaban
apixaban
edoxaban

49
Q

What are some blackbox warnings for DOACs?

A
  • stopping prematurely can increase ischemic events or clot
  • if discontinued, consider using another anticoagulant
  • epidural/spina hematomas and spinal procedures
50
Q

For treatment of VTE, what DOACs can be used regardless of high BMI and weight?

A

rivaroxaban or apixaban

51
Q

How do you reverse warfarin?

A

phytonadione
PCC (prothrombin complex concentrate)

52
Q

How should you assess bleeding risk? what is the acronym?

A
  • Hypertension
  • A bnormal renal and liver function
  • Stroke
  • Bleeding tendency or predisposition
  • Labile INR
  • Elderly (greater than 65 years old
  • Drugs (concamitant aspirin or NSAIDs or excess alcohol use
53
Q

duration of anticoagulation therapy if the clot is provoked?

A

transient/temporary risk factor
* complete anticoagulation after finishing primary treatment (3-6 months)

chronic risk factor
* continue anticoagulation indefinitely for secondary prevention after primary treatment

54
Q

duration of therapy if a clot was unprovoked?

A
  • continue anticoagulation indefinitely for secondary prevention after primary treatment